# New Onset Diabetes Management for Earlier Detection of Pancreatic Cancer (NODMED)

> **NCT05188586** · NA · TERMINATED · sponsor: **ClearNote Health** · enrollment: 26 (actual)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **OTHER:** MRI/Imaging

## Key facts

- **NCT ID:** NCT05188586
- **Lead sponsor:** ClearNote Health
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-10-31
- **Primary completion:** 2023-03-16
- **Final completion:** 2023-03-16
- **Target enrollment:** 26 (ACTUAL)
- **Why stopped:** enrollment targets not met
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05188586

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05188586, "New Onset Diabetes Management for Earlier Detection of Pancreatic Cancer (NODMED)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05188586. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*